A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06829797 · RECRUITING
Trial details
- NCT number
- NCT06829797
- Sponsor
- Shandong Provincial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2028-02-29
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.